RT Journal Article
SR Electronic
T1 Predicting Emerging Themes in Rapidly Expanding COVID-19 Literature with Dynamic Word Embedding Networks and Machine Learning
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.14.21249855
DO 10.1101/2021.01.14.21249855
A1 Pal, Ridam
A1 Chopra, Harshita
A1 Awasthi, Raghav
A1 Bandhey, Harsh
A1 Nagori, Aditya
A1 Gulati, Amogh
A1 Kumaraguru, Ponnurangam
A1 Sethi, Tavpritesh
YR 2021
UL http://medrxiv.org/content/early/2021/05/05/2021.01.14.21249855.abstract
AB Evidence from peer-reviewed literature is the cornerstone for designing responses to global threats such as COVID-19. The collection of knowledge and interpretation in publications needs to be distilled into evidence by leveraging natural language in ways beyond standard meta-analysis. Several studies have focused on mining evidence from text using natural language processing, and have focused on a handful of diseases. Here we show that new knowledge can be captured, tracked and predicted using the evolution of unsupervised word embeddings and machine learning. Our approach to decipher the flow of latent knowledge in time-varying networks of word-vectors captured thromboembolic complications as an emerging theme in more than 77,000 peer-reviewed publications and more than 11,000 WHO vetted preprints on COVID-19. Furthermore, machine learning based prediction of emerging links in the networks reveals autoimmune diseases, multisystem inflammatory syndrome and neurological complications as a dominant research theme in COVID-19 publications starting March 2021.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially supported by the Wellcome Trust/DBT India Alliance Fellowship IA/CPHE/14/1/501504 awarded to Tavpritesh Sethi. We also acknowledge support from the Center of Excellence in Healthcare and the Center of Excellence in Artificial Intelligence at IIIT-Delhi.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study involved analysis of a publicly available database on COVID-19 literature maintained by the WHO at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data used in this study are publicly available from the WHO Covid-19 Global Literature on coronavirus disease maintained at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov. Our analysis and the interactive resource EvidenceFlow is publicly available in a user-friendly fashion at https://evidenceflow.tavlab.iiitd.edu.in/